Clinical Trial

S086 Tablets for Chronic Heart Failure With Reduced Ejection Fraction

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated November 3, 2022 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
A randomized, double-blind, positive-drug parallel controlled, multicenter phase III trial of the efficacy and safety of S086 tablets in patients with chronic heart failure with reduced ejection fraction (HFrEF)
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-09-21.
Trial Details
NCT Number NCT05553886
Lead Sponsor Shenzhen People's Hospital
Conditions Chronic Heart Failure With Reduced Ejection Fraction
Enrollment 5 participants
Start Date 2021-12-21
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2022-11-03